MedPath

Bipolar Needlescopic Enucleation Versus Vapoenucleation of BPH

Not Applicable
Completed
Conditions
Prostate Obstruction
Prostatic Hypertrophy, Benign
Prostatic Hyperplasia
Interventions
Procedure: Bipolar Vapo-Enucleation of the prostate
Procedure: Bipolar Needlescopic Enucleation of the prostate
Registration Number
NCT04331301
Lead Sponsor
Benha University
Brief Summary

Transurethral resection of the prostate (TURP) is the current standard procedure for men with prostate volume 30-80 gm. In case with large prostate adenoma (\>80 g), the resection time required by TURP is associated with increased risk of TUR syndrome, blood loss and other complications.

Many types of minimally invasive surgery exist along with new equipment and techniques. Many types of laser devices such as greenlight laser, thulium laser and holmium laser, are used to enucleate the prostate. Increasing evidence has proven their safety and efficacy However, the use of laser devices is difficult and associated with steep learning curve and high medical expenses.

PKEP is a safe and effective procedure for the treatment of bladder obstruction secondary to BPH. This procedure not only improves maximum flow rate at 3 and 12 months after surgery, but it also improves all other recorded parameters (IPSS, QOL, IEFF-5, PVR, PSA).

A button electrode can be effectively used to enucleate the prostate because of its powerful vaporisation and strong coagulation (B-TUEP technique) ,such as that with a holmium laser, thulium laser and greenlight laser. However its associated with short term complication as early irritative symptoms, Bulai reported that 16.7% of the patients suffering from early irritative symptoms while Geavlete reported that 11.4% of patient suffering from early irritative symptoms.

Detailed Description

Aim: compare safety and efficacy and adverse events of endoscopic enucleation of large prostate using hot knife electrode (needloscopic enucleation) versus the standard vaporization electrode ( vapoenucleation) patients \& methods: Patients will randomly be divided into two equal groups: Group A: Patient will be subjected to bipolar endoscopic enucleation of the prostate by vaporization electrode (vapoenucleation).

Group B: Patient will be subjected to endoscopic enucleation of the prostate by bipolar hot kife electrode (needloscopic enucleation) Inclusion criteria: patients with Qmax of less than 15 mL/second due to BPH, severe LUTS/BPH requiring surgical treatment, and International Prostate Symptom Score (IPSS)\>7 due to BPH.

exclusion criteria: prostate and/or bladder cancer, bladder diverticula, urethral stricture, active urinary tract infection (UTI), unless treated, and men with neurogenic voiding dysfunction.

Operative Technique: Endoscopic enucleation of the prostate in saline utilizing either bipolar vaporization electrode or bipolar hot knife (collin's) electrode.

follow up: operative time, resected tissue weight, cath time, hospital stay and change of; IPSS,QOL, Qmax, PVR, PSA, IIEF-5 \& MSHQ-EjD besides; perioperative adverse events are recorded \& followed-up.

Recruitment & Eligibility

Status
COMPLETED
Sex
Male
Target Recruitment
214
Inclusion Criteria
  • patients with Qmax of less than 15 mL/second due to BPH, severe LUTS/BPH requiring surgical treatment, and International Prostate Symptom Score (IPSS)>7 due to BPH.
Exclusion Criteria
  • prostate and/or bladder cancer, bladder diverticula, urethral stricture, active urinary tract infection (UTI), unless treated, and men with neurogenic voiding dysfunction.

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Arm && Interventions
GroupInterventionDescription
vapoenucleation groupBipolar Vapo-Enucleation of the prostateGroup A
needlescopic enucleationBipolar Needlescopic Enucleation of the prostategroup B
Primary Outcome Measures
NameTimeMethod
IPSSchange of IPSS from Basline at 1,3 and 6 months postoperatively

international prostate symptoms score (range 0 -35, the lower value is better)

Secondary Outcome Measures
NameTimeMethod
TRUS measured prostate volumeChange of PV from Basline at 1,3 and 6 months postoperatively

Prostate volume measured by Transrectal Ultrasonography the lower value is better

QmaxChange of Qmax from Basline at 1,3 and 6 months postoperatively

maximum urinary flow rate (it ranges from 0(retention) to 25 mL/s or more the higher value is better)

QOLChange of QOL from Basline at 1,3 and 6 months postoperatively

Quality of life questionnaire (range 0 - 6, the lower value is better)

PVRUChange of PVRU from Basline at 1,3 and 6 months postoperatively

Post-operative residual urine (volume it ranges from 0 ml (normal) to more than 1 liter the lower value is better

Trial Locations

Locations (1)

Banha University Hospitals

🇪🇬

Banhā, Kalubyia, Egypt

© Copyright 2025. All Rights Reserved by MedPath